About Michele Cucullu
Form D filings for Brenig Therapeutics in 2024 list Michele Cucullu as director.
Michele Cucullu first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Michele Cucullu in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Michele Cucullu works with at each company, as listed on that company's latest Form D.
Brenig Therapeutics, Inc. · Form D, Jul 30, 2024
KG
Keno Gutierrez
Director
ID
Iain Dukes
Executive officer and director
EM
Edward Mathers
Director
NS
Nikolay Savchuk
Chief Executive Officer and director